Lisa Raines, vice president for government relations at theIndustrial Biotechnology Association, was named vice presidentfor government relations at Genzyme Corp. of Cambridge, Mass.
Celgene Corp. of Warren, N.J., named Thomas Odiorne presidentand chief operating officer. Odiorne was president of thepharmaceutical development group of Johnson & Johnson.
Phillip Radlick was appointed president and chief executiveofficer of Hepatix Inc. of Houston. He was group vice presidentfor business development and strategic planning with thecardiovascular surgery group at Baxter Healthcare Co.
Una Ryan was named vice president of research and chiefscientific officer at T Cell Sciences of Cambridge, Mass. Ryanwas director of health sciences at Monsanto.
Collaborative Research Inc. elected to its board of directorsRobert Hennessey, president and chief executive officer of theWaltham, Mass., company.
Louis Matis, senior investigator in the laboratory of molecularimmunoregulation at the National Cancer Institute, was nameddirector of immunobiology at Alexion Pharmaceuticals Inc. ofNew Haven, Conn.
Seragen Inc. of Hopkinton, Mass., elected George Masters vicechairman of the board and chairman of the executivecommittee. Masters was president and chief executive officer ofHemosol Inc., a biopharmaceutical company.
Per-Olof Martensson was elected a director of Skandigen AB ofStolkholm, Sweden. Martensson was executive vice president ofPharmacia AB.
(c) 1997 American Health Consultants. All rights reserved.